Premise: FDA finds that the one-time cost of compliance for each product, estimated to be $600, should be manageable for small entities even if they manufacture 10 to 20 products that require relabeling at a cost of $6,000 to $12,000.

Hypothesis: It would be impossible for small entities to afford the one-time cost of compliance.
Relation: contradiction